MKI67 and neoplasm: Inter-laboratory reproducibility of Ki-67 proliferating antigen testing on forty cases of invasive breast carcinoma by each of the 10 participating laboratories, utilizing the thresholds of ≥30% and ≥20% for positivity of invasive tumor cells.